首页 › 非肌层浸润性膀胱癌 › 田纳西州 › Nashville
Nashville TN 非肌层浸润性膀胱癌临床试验
8项针对 非肌层浸润性膀胱癌的研究正在 Nashville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
招募中2 期
- Urology Associates PC, Nashville
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
招募中1 期
- Urology Associates, P.C., Nashville
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
招募中2 期
- Urology Associates PC, Nashville
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- Sarah Cannon and HCA Research Institute, Nashville
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
招募中1/2 期
- Urology Associates, P.C., Nashville
- Vanderbilt Univerity Medical Center, Nashville
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
招募中观察性研究
- Vanderbilt University Medical Center, Nashville
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
招募中1/2 期
- Urology Associates, P.C., Nashville
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
招募中2 期
- Site 02-007 - Urology Associates, P. C, Nashville
其他城市的 非肌层浸润性膀胱癌试验
- Columbus, OH10 项研究
- Dallas, TX10 项研究
- New York City, NY10 项研究
- Myrtle Beach, SC9 项研究
- Edison, NJ9 项研究
- Baltimore, MD8 项研究
- Syracuse, NY8 项研究
- Houston, TX7 项研究
- Indianapolis, IN7 项研究
- Birmingham, AL7 项研究
- Philadelphia, PA7 项研究
- Atlanta, GA7 项研究
Nashville的其他研究
- 非小细胞肺癌97 项研究
- 乳腺癌81 项研究
- 转移性癌症70 项研究
- 结直肠癌69 项研究
- 癌症（所有类型）65 项研究
- 卵巢癌49 项研究
- 前列腺癌43 项研究
- 肺癌40 项研究
- 头颈鳞状细胞癌39 项研究
- 胰腺癌39 项研究
- 子宫内膜癌38 项研究
- 黑色素瘤33 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。